Anti-oncogenic activity of novel compounds and reference drugs <i>in vitro</i>. KASUMI-1 cells were treated with a series of FLT3/TAF1 compounds and cell viability was determined using a CellTiter Glo assay, while cell toxicity was determined using a
(A) Compound activity in KASUMI-1 cells at 0.001-30 µM (n = 1). (B) IC<sub>50</sub> values of FLT3/TAF1 inhibitors. Each dose-response curve represents an independent experiment. Dots represent individual data points and the gray area represents the 95% confidence interval for each curve. Both single FLT3 inhibitors (3i-1244, 3i-1245, 3i-1247) and dual FLT3/TAF1 inhibitors (3i-1103, 3i-1246, 3i-1248) were used for experiments. (PDF)
Publication Details
- Journal
- Figshare
- Published
- 2025-03-28
- DOI
- https://doi.org/10.1371/journal.pone.0320443.s008
- Primary Topic
- Cell death mechanisms and regulation
- Type
- article
- Field-Weighted Citation Impact
- 0.00